Evidence map›Paper›PMID 25662996›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Quantitative reduction of the TCR adapter protein SLP-76 unbalances immunity and immune regulation.

Owen M Siggs, Lisa A Miosge, Stephen R Daley, Kelly Asquith, Paul S Foster, Adrian Liston, Christopher C Goodnow

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. WGCNA and molecular docking identify hub genes for cardiac aging.Frontiers in cardiovascular medicine · 2023
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Owen M SiggsDepartment of Immunology, John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory 2601, Australia; Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 1SA, United Kingdom; owen.siggs@sanger.ac.uk chris.goodnow@anu.edu.au.
Lisa A MiosgeDepartment of Immunology, John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory 2601, Australia;
Stephen R DaleyDepartment of Immunology, John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory 2601, Australia;
Kelly AsquithPriority Research Centre for Asthma and Respiratory Diseases, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales 2300, Australia; and.
Paul S FosterPriority Research Centre for Asthma and Respiratory Diseases, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, New South Wales 2300, Australia; and.
Adrian ListonDepartment of Microbiology and Immunology, Flanders Institute for Biotechnology and University of Leuven, Leuven 3000, Belgium.
Christopher C GoodnowDepartment of Immunology, John Curtin School of Medical Research, Australian National University, Canberra, Australian Capital Territory 2601, Australia; owen.siggs@sanger.ac.uk chris.goodnow@anu.edu.au.
Australian National University · AUUniversity of Newcastle Australia · AURega Institute for Medical Research · BE

Funding

Systems Biology CoreU19AI100627 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI ULEVITCH, RICHARD J · 2012 to 2021
$49.1M
Systems Approach to Innate Immunity-Inflammation-SepsisU54AI054523 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI ULEVITCH, RICHARD J · 2002 to 2006
$28.0M
Genes for Tolerance and Immunity ConsortiumR01AI052127 · NIAID · AUSTRALIAN NATIONAL UNIVERSITY · PI GOODNOW, CHRISTOPHER CARL · 2002 to 2006
$6.3M
NIAID NIH HHS R01 AI052127NIAID NIH HHS R01 AI52127NIAID NIH HHS U19 AI100627NIAID NIH HHS U54 AI054523Wellcome Trust 082030Wellcome Trust 100083
6 · The paper itself

Abstract

Gene variants that disrupt TCR signaling can cause severe immune deficiency, yet less disruptive variants are sometimes associated with immune pathology. Null mutations of the gene encoding the scaffold protein Src homology 2 domain-containing leukocyte protein of 76 kDa (SLP-76), for example, cause an arrest of T cell positive selection, whereas a synthetic membrane-targeted allele allows limited positive selection but is associated with proinflammatory cytokine production and autoantibodies. Whether these and other enigmatic outcomes are due to a biochemical uncoupling of tolerogenic signaling, or simply a quantitative reduction of protein activity, remains to be determined. In this study we describe a splice variant of Lcp2 that reduced the amount of wild-type SLP-76 protein by ~90%, disrupting immunogenic and tolerogenic pathways to different degrees. Mutant mice produced excessive amounts of proinflammatory cytokines, autoantibodies, and IgE, revealing that simple quantitative reductions of SLP-76 were sufficient to trigger immune dysregulation. This allele reveals a dose-sensitive threshold for SLP-76 in the balance of immunity and immune dysregulation, a common disturbance of atypical clinical immune deficiencies.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsAntibodies, AntinuclearBlotting, WesternCytokinesFemaleFlow CytometryImmunityImmunoglobulin EImmunoglobulin GInflammation MediatorsMaleMice, Inbred C57BLMice, Mutant StrainsMice, TransgenicMutationAdaptor Proteins, Signal TransducingAntibodies, AntinuclearCytokinesImmunoglobulin EImmunoglobulin GInflammation MediatorsPhosphoproteinsSLP-76 signal Transducing adaptor proteins

Identifiers

PMID25662996
PMCPMC4355390
OpenAlexW1854247600

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.